About Us
Senior Vice Chairman of the Board, Executive Director: Mr. Tse Ping
-
- Senior Vice Chairman of the Board, Executive Director: Mr. Tse Ping
- Mr. Tse Ping is the founding chairman of the Company and now serves as Senior Vice Chairman of the Board, an Executive Director, and a member of the Executive Board Committee. Mr. Tse has over 30 years of extensive experience in investment and management in the pharmaceutical industry in China.
Mr. Tse Ping is currently the president of NJCTT, Jiangsu CT Fenghai, Jiangsu CT Qingjiang, and Chia Tai Pharmaceutical Investment (Beijing) Group Co., Ltd., and a director of CT Tianqing and Beijing Tide. Mr. Tse Ping is also a senior vice president of Charoen Pokphand Group, the president of CP Pharmaceutical Group, and a director of Shanghai Fortune World Development Co., Ltd., Tianjin Chiatai Feed Tech Co., Ltd., SYN Energy Technology Co., Ltd., and Chia Tai Oversea Chinese Realty Development Co., Ltd.
Soon after the adoption of the open-up and reform policy by China, Mr. Tse Ping started to develop his investment and business in China. He has been engaged in the pharmaceutical industry since 1991, having made equity investments in a dozen or so enterprises, and is one of the most successful overseas investors in the PRC pharmaceutical industry. Led by Mr. Tse Ping, CP Pharmaceutical Group has developed to a large integrated pharmaceutical enterprise, and its Hong Kong listed flagship Sino Biopharmaceutical Limited is a constituent of the Heng Seng Index, owning a number of national key high-technology enterprises. Adhering to the concept of technology innovation and building upon R&D system based on originality as well as imitation, the Group strives to develop international level, high-end biological drugs and innovative drugs and to achieve breakthroughs in different areas including medical services, medical equipment, and mergers and acquisitions, and becomes an innovation driven pharmaceutical conglomerate with its business encompassing the entire industry chain which spans from R&D to manufacture and sales of pharmaceutical products. Since incorporation, the Company continues to break its own record in terms of revenue and net profit, and was included in American Magazine Pharm Exec's "Top 50 Companies" for six consecutive years from 2019 to 2024 and was ranked one of the "Asia Fab 50 Companies" by Forbes Asia for three consecutive years.
As a recognition for his efforts in promoting the development of the pharmaceutical industry in China, Mr. Tse Ping was awarded a number of honours, including the prize of "World Outstanding Chinese" and an honorary Doctor Degree by the University of West Alabama, United States of America in January 2008, and the "2007/2008 Asian Knowledge Management Association academician" granted by the Asian Knowledge Management Association in December 2008.
Mr. Tse Ping was a member of the Ninth, Tenth and Eleventh National Committee of the Chinese People's Political Consultative Conference. He is currently an executive vice chairman of the China Overseas Chinese Entrepreneurs Association and a distinguished professor of University for Peace, UPEACE.
*Portrait rights belong to the individual. Unauthorized use is prohibited.
